| pubmed-article:9016680 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9016680 | lifeskim:mentions | umls-concept:C0035668 | lld:lifeskim |
| pubmed-article:9016680 | lifeskim:mentions | umls-concept:C0021920 | lld:lifeskim |
| pubmed-article:9016680 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:9016680 | lifeskim:mentions | umls-concept:C2718002 | lld:lifeskim |
| pubmed-article:9016680 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:9016680 | lifeskim:mentions | umls-concept:C0441843 | lld:lifeskim |
| pubmed-article:9016680 | pubmed:issue | 24 | lld:pubmed |
| pubmed-article:9016680 | pubmed:dateCreated | 1997-3-11 | lld:pubmed |
| pubmed-article:9016680 | pubmed:abstractText | High-throughput screening assays have been developed to rapidly identify small molecule inhibitors targeting catalytic group I introns. Biochemical reactions catalyzed by a self-splicing group I intron derived from Pneumocystis carinii or from bacteriophage T4 have been investigated. In vitro biochemical assays amenable to high-throughput screening have been established. Small molecules that inhibit the functions of group I introns have been identified. These inhibitors should be useful in better understanding ribozyme catalysis or in therapeutic intervention of group I intron-containing microorganisms. | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9016680 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9016680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9016680 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9016680 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9016680 | pubmed:issn | 0305-1048 | lld:pubmed |
| pubmed-article:9016680 | pubmed:author | pubmed-author:HoD YDY | lld:pubmed |
| pubmed-article:9016680 | pubmed:author | pubmed-author:HamM WMW | lld:pubmed |
| pubmed-article:9016680 | pubmed:author | pubmed-author:ChungF ZFZ | lld:pubmed |
| pubmed-article:9016680 | pubmed:author | pubmed-author:TruongH NHN | lld:pubmed |
| pubmed-article:9016680 | pubmed:author | pubmed-author:CzarnikA WAW | lld:pubmed |
| pubmed-article:9016680 | pubmed:author | pubmed-author:SuttonS TST | lld:pubmed |
| pubmed-article:9016680 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9016680 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:9016680 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:9016680 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9016680 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9016680 | pubmed:pagination | 5051-3 | lld:pubmed |
| pubmed-article:9016680 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:9016680 | pubmed:meshHeading | pubmed-meshheading:9016680-... | lld:pubmed |
| pubmed-article:9016680 | pubmed:meshHeading | pubmed-meshheading:9016680-... | lld:pubmed |
| pubmed-article:9016680 | pubmed:meshHeading | pubmed-meshheading:9016680-... | lld:pubmed |
| pubmed-article:9016680 | pubmed:meshHeading | pubmed-meshheading:9016680-... | lld:pubmed |
| pubmed-article:9016680 | pubmed:meshHeading | pubmed-meshheading:9016680-... | lld:pubmed |
| pubmed-article:9016680 | pubmed:meshHeading | pubmed-meshheading:9016680-... | lld:pubmed |
| pubmed-article:9016680 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:9016680 | pubmed:articleTitle | Inhibition of self-splicing group I intron RNA: high-throughput screening assays. | lld:pubmed |
| pubmed-article:9016680 | pubmed:affiliation | Department of Chemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48106, USA. meih@aa.wl.com | lld:pubmed |
| pubmed-article:9016680 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9016680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9016680 | lld:pubmed |
